Watch Ticker

ARS Pharmaceuticals, Inc. Common Stock

Go to ARS Pharmaceuticals, Inc. Common Stock Website

$17.80

0.00 (0.00%)
Live
Previous Close

$17.8

Day Range

$0 - $0

Previous Day Range

$17.23 - $18

Market Cap

$1.7 billion USD

Day Vol.

0

Previous Day Vol.

942957

Currency

USD

Primary Exchange

Nasdaq

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary co...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

ARS Pharmaceuticals has filed for approval of its epinephrine nasal spray 'neffy' in Canada and the United Kingdom, where it will be marketed as 'EURneffy', on behalf of its licensing partner ALK-Abelló A/S. The filing is part of the company's efforts to expand the global availability of this life-saving treatment for severe allergic reactions.

Related tickers: SPRY.

Read Full Article

ARS Pharmaceuticals announced that its licensing partners in China, Japan, and Australia have filed for regulatory approval of its epinephrine nasal spray, neffy, for the treatment of type I allergic reactions including anaphylaxis. The company is focused on making this life-saving treatment widely available globally.

Related tickers: SPRY.

Read Full Article
Trending Tickers

Please sign in to view